Serum nifedipine concentrations and response of patients with pulmonary hypertension

American Journal of Cardiology

Volumn 77, Issue 11, 1996, Pages 996-999

  Phillips, Bradley G ^a   Bauman, Jerry L ^a   Schoen, Marieke D ^a   Hoon, Timothy J ^a   Schrader, Bruce J ^a   Rich, Stuart ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0029890360     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00037-9     Document Type: Article

References (10)

1. Olivari MT, Levine TB, Weir EK, Cohn JN. Hemodynamic effects of nifedipine at rest and during exercise in primary pulmonary hypertension. Chest 1984;86:14-19.
2. Packer M, Medina N, Yushak M. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease. J Am Coll Cardiol 1984;4:890-901.
3. Rich S, Ganz R, Levy PS. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension. Am J Cardiol 1983;52:1104-1107.
4. Rich S, Brundage BH. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 1987;76:135-141.
5. Rich S, Kaufmann E. High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guideline for short-term drug testing. J Am Coll Cardiol 1991;18:1323-1327.
6. Rich S, Brundage BH, Levy PS. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Circulation 1985;71:1191-1196.
7. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, Levy PC, Reid LM, Vreim CE, Williams GW. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216-223.
8. Gurley BJ, Buice RG, Sidhu P. Reverse-phase high performance liquid chromatography determination of nifedipine in human plasma. Ther Drug Monit 1985;7:321-323.
9. Breimer DD, Schellens JHM, Soons PA. Nifedipine: variability in its kinetics and metabolism in man. Pharmacol Ther 1989;44:445-454.
10. Gutierrez LM, Lesko LJ, Whipps R, Carliner N, Fisher M. Pharmancokinetics and pharmacodynamics of nifedipine in patients at steady state. J Clin Pharmacol 1986;26:587-592.